Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson’s disease

1. Requejo, C.
2. Ruiz-Ortega, J.A.
3. Bengoetxea, H.
4. Bulnes, S.
5. Ugedo, L.
6. Lafuente, J.V.